We have lots of drug options, and we’re getting new ones still,” Kristin H.
According to Market Scope data, of the $6.1 billion in the global glaucoma product market in 2021, pharmaceuticals accounted for 80%, devices for 13% and diagnostic equipment for 7%, she said.